MétaCan
Menu
Back to cohort

A randomized controlled trial of flunarizine as add‐on therapy and effect on cognitive outcome in children with infantile spasms

2012· article· en· W1962248645 on OpenAlexafffundabout
Jonathan Bitton, Hannelore C. Sauerwein, Shelly K. Weiss, Elizabeth Donner, Sharon Whiting, Joseph M. Dooley, Carter Snead, K Farrell, Elaine Wirrell, Ismail Mohamed, Gabriel M. Ronen, Milagros Salas‐Prato, Devendra Amre, Maryse Lassonde, Lionel Carmant

Bibliographic record

VenueEpilepsia · 2012
Typearticle
Languageen
FieldMedicine
TopicEpilepsy research and treatment
Canadian institutionsHealth Sciences CentreMcMaster University Medical CentreAlberta Children's HospitalIzaak Walton Killam Health CentreUniversity of CalgaryChildren's Hospital of Eastern OntarioUniversity of OttawaUniversity of British ColumbiaUniversité de MontréalHospital for Sick ChildrenBC Children's HospitalCentre Hospitalier Universitaire Sainte-JustineDalhousie UniversityUniversity of TorontoSickKids Foundation
FundersCanadian Institutes of Health ResearchEisai CanadaH. Lundbeck A/SSavoy Foundation
KeywordsFlunarizineVigabatrinBayley Scales of Infant DevelopmentVineland Adaptive Behavior ScalePediatricsPlaceboRandomized controlled trialMedicineHypsarrhythmiaPsychologyAnesthesiaAnticonvulsantEpilepsyInternal medicinePsychomotor learningPsychiatryCognition

Abstract

fetched live from OpenAlex

PURPOSE: Cognitive impairment is observed commonly in children with a history of infantile spasms (IS). The goal of this study was to prospectively examine the effect on cognitive outcome of a neuroprotective agent used as adjunctive therapy during treatment of the spasms. METHODS: In a randomized controlled trial, patients received a standardized therapy plus flunarizine or placebo. The standardized treatment consisted of vigabatrin as first-line therapy. Nonresponders were switched to intramuscular synthetic adrenocorticotropic hormone (sACTH depot) after 2 weeks and, if necessary, to topiramate after two additional weeks. The Vineland Adaptive Behavior Scale (VABS) and Bayley Scales of Infant Development (BSID) were used as outcome measures 24 months after the intervention. KEY FINDINGS: Sixty-eight of 101 children diagnosed over 3 years in seven centers in Canada received either adjunctive flunarizine or placebo. Sixty-five of the 68 children (96%) became spasm-free within 8 weeks and no late relapse occurred. Bayley and Vineland results were available at baseline and at 24 months in 45 children. There was no significant difference in the BSID developmental quotient between the flunarizine- and placebo-treated children at baseline (44.3 ± 35.5 vs. 30.9 ± 29.8; p = 0.18) or 24 months later (56.9 ± 33.3 vs. 46 ± 34.2; p = 0.29). However, the 10 flunarizine-treated children with no identified etiology had a better outcome than the eight controls at 24 months on both the Vineland Scale (84.1 ± 11.3 vs. 72.3 ± 9.8; p = 0.03) and the Bayley Scale (87.6 ± 14.7 vs. 69.9 ± 25.3; p = 0.07). SIGNIFICANCE: Our study failed to demonstrate a protective effect of flunarizine on cognitive outcome in a cohort of children with IS. An analysis of subgroups suggested that flunarizine may further improve cognitive outcome in children with no identified etiology.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.125
Threshold uncertainty score0.573

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.324
Teacher spread0.307 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2012
Admission routes3
Has abstractyes

Explore more

Same venueEpilepsiaSame topicEpilepsy research and treatmentFrench-language works237,207